Want to join the conversation?
$CPB raised its outlook for adjusted EBIT and EPS and sales guidance lowered to reflect impact from currency headwinds. $CPB now expects sales to grow by negative 1% to 0%, adjusted EBIT to grow by 4-7% and adjusted EPS to grow by 4-7%, or $2.75-2.83 per share.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.